Similarly, comparing two sub-lines of prostate cancer cells PC-3 (32), the more mesenchymal one (PC-3/S) showed higher levels of PD-L1, ZEB1, and SLUG relative to the hybrid E/M PC-3/Mc cells (Figure 1H). This evidence concerns the gene ZEB1 and prostate carcinoma.